3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
10
Neoplasms
6
Anxiety Disorders
6
Head and Neck Neoplasms
3
Depression
3
Ovarian Neoplasms
2
Hot Flashes
2
Chronic Pain
2
Xerostomia
1
Vomiting
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Tendinopathy
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sarcoma
1
Radiculopathy
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pathophobia
1
Pain, Postoperative
1
Pain
1
Nociceptive Pain
1
Neuralgia, Postherpetic
1
Neuralgia
1
Nausea
1
Myocarditis
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Interventions
Etoposide
17
Filgrastim
16
Carboplatin
16
Ifosfamide
15
Peripheral Blood Stem Cell Transplantation
14
Cisplatin
14
Paclitaxel
12
Cyclophosphamide
8
Bleomycin
7
Radiotherapy
6
pegfilgrastim
4
Thiotepa
4
etoposide phosphate
3
sargramostim
2
aldesleukin
2
Vinblastine
2
Temozolomide
2
Methylprednisolone
2
Magnetic Resonance Spectroscopy
2
Immunohistochemistry
2
Granisetron
2
Gemcitabine
2
Dexamethasone
2
Busulfan
2
Alemtuzumab
2
tislelizumab
1
sabarubicin
1
milademetan
1
lerisetron
1
ixabepilone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Testicular Germ Cell Tumor
×
Hypnosis
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled